Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A Pediatric Therapeutic Gap in the Emerging Stage-Specific Treatment of Type 1 Diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
10.1056/nejmoa1902226 · 2019 · External reference
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
10.1056/nejmoa2308743 · 2023 · External reference
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
10.1007/s00125-025-06586-1 · 2026 · External reference
Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
10.1001/jamapediatrics.2025.2740 · 2025 · External reference
Stem cell-derived, fully differentiated islets for type 1 diabetes
10.1056/nejmoa2506549 · 2025 · External reference
